Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, September 11, 2020
Direct Biologics will leverage Bioclinica's Interactive Response Technology (IRT) for their EXIT COVID-19 study.
read more
Thursday, October 04, 2012
BioClinica®, Inc., a global provider of clinical trial management solutions, today announced that members of its team will attend, participate in and lead discussions at several upcoming industry conferences in October, November, and December. ...
read more
Wednesday, April 18, 2012
BioClinica®, Inc., (NASDAQ: BIOC), a global provider of clinical trial management solutions, today announced that members of its team will attend, participate in and speak at several upcoming industry conferences in April, May, and June. BioClinica ...
read more
BioClinica®, Inc. (NASDAQ: BIOC), a global provider of clinical trial management solutions, today announced that members of its team will attend, participate in and lead discussions at several upcoming industry conferences in July, August, and ...
read more
BioClinica®, Inc., a global provider of clinical trial management solutions, today announced that members of its team will attend, participate in and lead discussions at several upcoming industry conferences in January, February, and March. ...
read more
Wednesday, September 25, 2019
Biocon Biologics has acquired R&D capital assets for a 60,000 sq. ft ‘bench to pilot scale’ Biologics research facility at TICEL Bio Park in Chennai from Pfizer Healthcare India.
read more
BioConnection, an independent CDMO based in Oss, The Netherlands announced the completion of a new capital raising led by the European investment company Gimv, and supported by existing shareholders Pharming Group N.V., Mibiton and BioConnection’s ...
read more
Monday, November 29, 2021
BioConnection, an independent CDMO (Contract Development Manufacturing Organization) based in Oss, The Netherlands, specialized in GMP-certified manufacturing of sterile drug products in vials and syringes, today announced that Nykode Therapeutics AS...
read more
Biocytogen Pharmaceuticals announced the grand opening of a new 37,000 square foot facility in Waltham, MA for its US-based subsidiary, Biocytogen Boston Corporation.
read more
Tuesday, December 08, 2020
Beijing Biocytogen, Biocytogen Boston Corp, announced they have reached an agreement with Xencor, Inc., for the licensing of Biocytogen's fully human antibody RenMab/RenLite Mouse platform.
read more
Biocytogen Pharmaceuticals announced that its Project Integrum has completed 2 core milestones, and its antibody business is now entering a new stage of rapid growth.
read more
Thursday, December 03, 2015
BioDelivery Sciences International has appointed Joseph (Jody) M. Lockhart as Vice President of Manufacturing and Supply Chain.
read more
Tuesday, February 14, 2023
Biodextris Inc., a subsidiary of Clean Biologics SAS, announced the development of a new industrial-scale vaccine and biologics development, manufacturing and packaging plant (CDMO).
read more
Wednesday, March 30, 2016
Biodextris Inc. has announced its suite of services and commitment to building a full service contract organization. The new contract research organization (CRO) provides analytical and process development services for vaccines and biologics ...
read more
This collaboration brings together Atombeat’s in silico modeling expertise, AI-accelerated & data-driven design platform with BioDuro’s expertise in discovery chemistry, biology and DMPK to accelerate the development of next-generation peptides.
read more